Dabur OncQuest, a leader in Indian oncology medical testing market, has recently been accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) in accordance with ISO 15189:2003, which is specific to medical testing laboratories. This accreditation is valid for the next two years and Dabur OncQuest is the only specialized oncology medica0l testing focus laboratory to receive this recognition. Also, OncQuest has been awarded this accreditation in the shortest time.

NABL is an autonomous body under the aegis of Department of Science and Technology, Government of India, and is registered under the Societies Act. Government of India has authorized NABL as the sole accreditation body for medical Testing and Calibration laboratories.

OncQuest's new technologically advanced clinical and research laboratory is fully equipped with molecular technologies allowing for rapid advancement in the complex field of proteomics, genomics, and bioinformatics. OncQuest is one of its kind laboratories in South East Asia to have exclusively ventured in the area of Molecular Diagnostics and other advanced medical testing techniques. The new integrated research facility provides a strong foundation for Dabur OncQuest to grow within the field of genetic oncology. This laboratory is equipped to provide the most advanced proteins/antibodies and nucleic acid based diagnostic and prognostic tests for the better and more accurate diagnosis and management of cancer.

On receiving the accreditation, Vivek Trikha, head-diagnostics, Dabur OncQuest said, "This accreditation has given an impetus to our mission of extending the survival and improving the quality of life of cancer patients by providing scientifically advanced, cost-effective molecular diagnostics tests."

Dabur OncQuest started its operations in 2003 and has introduced a number of techniques to evaluate the structure of DNA, RNA or Proteins in cells.